Sensa Neuroscience

Sensa Neuroscience is advancing a next-generation cannabinoid platform for drug-resistant epilepsies, led by SEN-126, a differentiated CBD analog designed to improve oral bioavailability and unlock new therapeutic potential in high-need, underserved markets.